| Heading: |
Drugs |
| Question ID: |
1751216 |
| UIN: |
21121 |
| House: |
Commons |
| Date tabled: |
2024-12-18 |
| Asking Member ID: |
5262 |
| Asking Member display name: |
Alex Easton
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Alex Easton
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps the Government is taking to review the regulations surrounding the sale of potent medications such as (a) finasteride, (b) dutasteride, and (c) selective serotonin reuptake inhibitors vi |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-01-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
There are no current plans to review the legal avenues of online prescribing and the dispensing of prescription-only medications.Decisions about what medicines to prescribe are made by the doctor or healthcare professional responsible for that part of the... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |